This website is intended for healthcare professionals

Tom Allaway

Editor

Updates: May 2021

The National Institute for Health and Care Excellence (NICE) announced on the 4 May 2021 that more people the rare genetic disorder spinal muscular atrophy (SMA) will be able to benefit from...

A time for reflection

This has been a month of progress and reflection here in the United Kingdom. As restrictions start to lift after many difficult months of lockdown, I'm sure, like me, you find yourselves having to...

Updates: May 2021

The National Institute for Health and Care Excellence (NICE) announced on the 4 May 2021 that more people the rare genetic disorder spinal muscular atrophy (SMA) will be able to benefit from...

Progress in practice

Sometimes it is hard to quantify the progress being made in the wider world, but seeing these small victories within your family really brings home the significant work and progress we have made since...

Fresh and familiar challenges greet us in 2021

wrote my first draft of this editorial before Christmas, apprehensively waiting with bated breath to see just how the lift of restrictions for the holiday season would affect us going forward. Of...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP